A PIPELINE POWERED BYPASSION
PUBLICATIONS AND PRESENTATIONS
Prevalence and Excess Risk of Hospitalization in Heart Failure with Reduced Ejection Fraction
Poster, HFSA 2022 Annual Scientific Meeting
Desai, NR, et al
Washington, DC
October 1, 2022
Safety, Efficacy, and Quantitative Understanding of Obstruction, Impact of Aficamten in Hypertrophic Cardiomyopathy (SEQUOIA-HCM) Study Design: A Phase 3 Study
Poster, HFSA 2022 Annual Scientific Meeting
Coats C, et al
Washington, DC
October 1, 2022
Withdrawal of Background Standard of Care Medical Therapy in Patients with Obstructive Hypertrophic Cardiomyopathy Treated with Aficamten in REDWOOD HCM OLE
Presentation, 2022 HCM Society Scientific Sessions
Masri A, et al
National Harbor, MD
September 30, 2022
A Phase 1 Dose-Escalation Study of the Cardiac Myosin Inhibitor Aficamten in Healthy Participants
JACC: Basic to Translational Science
Malik FI, et al
August 10, 2022
Characterizing Hospitalization as an Outcome Measure in ALS Clinical Trials
Poster, European Network for the Cure of ALS (ENCALS), 2022
Simmons Z, et al
Edinburgh, UK
June 1, 2022